- 8% royalties on annualises rev = ~6m
- milestone (one-off) payments only when hit threshold = $5m. Mayne needs to hit $100m in revenue from these products before milestone payments.
- $140m = great deal for patent protected products with established market presence and revenue stream to the tune of $80m pa. Unlike nextstellis, TMD already did the heavy lifting of launching and creating rev streams for these products.
- gross margin for these products are 80% - similar GM as nextstellis
Ann: MYX signs license agreement for women's health products, page-107
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.40 |
Change
0.140(3.29%) |
Mkt cap ! $374.3M | |||
| Open | High | Low | Value | Volume |
| $4.25 | $4.43 | $4.25 | $618.9K | 141.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2957 | $4.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.41 | 968 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |